Publication: Design, synthesis and biological evaluation of novel benzocoumarin derivatives as potent inhibitors of MAO-B activity
dc.contributor.author | MELETLİ, FURKAN | |
dc.contributor.author | DEMİR, SERAP | |
dc.contributor.author | DANIŞ, ÖZKAN | |
dc.contributor.authors | MELETLİ F., Gündüz C., Alparslan M. M., ATTAR A., DEMİR S., İskit E., DANIŞ Ö. | |
dc.date.accessioned | 2024-10-14T17:17:27Z | |
dc.date.available | 2024-10-14T17:17:27Z | |
dc.date.issued | 2024-11-15 | |
dc.description.abstract | The continued research of novel reversible inhibitors targeting monoamine oxidase (MAO) B remains crucial for effectively symptomatic treatment of Parkinson\"s disease. In this study we synthesized and evaluated a new series of 3-aryl benzo[g] and benzo[h] coumarin derivatives as MAO-B inhibitors. Compound A6 has been found to display the most potent inhibitory activity and selectivity against the MAO-B isoform (IC50 = 13 nM and SI = >7693.31 respectively). Inhibition mode of A6 on MAO-B was predicted as mixed reversible inhibition with a Ki value of 3.274 nM. Furthermore, in order to elaborate structure–activity relationships, the binding mode of A6 was investigated by molecular docking simulations. | |
dc.identifier.citation | MELETLİ F., Gündüz C., Alparslan M. M., ATTAR A., DEMİR S., İskit E., DANIŞ Ö., "Design, synthesis and biological evaluation of novel benzocoumarin derivatives as potent inhibitors of MAO-B activity", Bioorganic and Medicinal Chemistry Letters, cilt.113, 2024 | |
dc.identifier.doi | 10.1016/j.bmcl.2024.129984 | |
dc.identifier.issn | 0960-894X | |
dc.identifier.uri | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85205697263&origin=inward | |
dc.identifier.uri | https://hdl.handle.net/11424/298066 | |
dc.identifier.volume | 113 | |
dc.language.iso | eng | |
dc.relation.ispartof | Bioorganic and Medicinal Chemistry Letters | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.subject | Tıp | |
dc.subject | Yaşam Bilimleri | |
dc.subject | Biyoteknoloji | |
dc.subject | Moleküler Biyoloji ve Genetik | |
dc.subject | Sitogenetik | |
dc.subject | Kimya | |
dc.subject | Biyokimya | |
dc.subject | Biyoinorganik Kimya | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Temel Bilimler | |
dc.subject | Medicine | |
dc.subject | Life Sciences | |
dc.subject | Biotechnology | |
dc.subject | Molecular Biology and Genetics | |
dc.subject | Cytogenetic | |
dc.subject | Chemistry | |
dc.subject | Biochemistry | |
dc.subject | Bioinorganic Chemistry | |
dc.subject | Health Sciences | |
dc.subject | Natural Sciences | |
dc.subject | Klinik Tıp (Med) | |
dc.subject | Temel Bilimler (Sci) | |
dc.subject | Yaşam Bilimleri (Life) | |
dc.subject | Klinik Tıp | |
dc.subject | Moleküler Biyoloji Ve Genetik | |
dc.subject | Mikrobiyoloji | |
dc.subject | Tropikal Tıp | |
dc.subject | Kimya Organik | |
dc.subject | Biyokimya Ve Moleküler Biyoloji | |
dc.subject | Biyoteknoloji Ve Uygulamalı Mikrobiyoloji | |
dc.subject | Clinical Medicine (Med) | |
dc.subject | Natural Sciences (Sci) | |
dc.subject | Life Sciences (Life) | |
dc.subject | Clinical Medicine | |
dc.subject | Molecular Biology & Genetics | |
dc.subject | Microbiology | |
dc.subject | Tropical Medicine | |
dc.subject | Chemistry Organic | |
dc.subject | Biochemistry & Molecular Biology | |
dc.subject | Biotechnology & Applied Microbiology | |
dc.subject | Moleküler Tıp | |
dc.subject | Moleküler Biyoloji | |
dc.subject | Farmasötik bilim | |
dc.subject | İlaç Keşfi | |
dc.subject | Klinik Biyokimya | |
dc.subject | Organik Kimya | |
dc.subject | Fizik Bilimleri | |
dc.subject | Molecular Medicine | |
dc.subject | Molecular Biology | |
dc.subject | Pharmaceutical Science | |
dc.subject | Drug Discovery | |
dc.subject | Clinical Biochemistry | |
dc.subject | Organic Chemistry | |
dc.subject | Physical Sciences | |
dc.subject | Benzo[g]coumarin | |
dc.subject | Benzo[h]coumarin | |
dc.subject | Molecular docking | |
dc.subject | Monoamine oxidase | |
dc.subject | Parkinson's Disease | |
dc.title | Design, synthesis and biological evaluation of novel benzocoumarin derivatives as potent inhibitors of MAO-B activity | |
dc.type | article | |
dspace.entity.type | Publication | |
local.avesis.id | f1ca3247-903a-4fea-b227-cabaf40e1e4b | |
local.indexed.at | SCOPUS | |
relation.isAuthorOfPublication | e691a304-c784-411a-9349-f69fc9e9682a | |
relation.isAuthorOfPublication | 2790d85f-c14d-4e37-8567-e89f9e168058 | |
relation.isAuthorOfPublication | 91b82a1e-bb32-4e40-ad53-90dcac92bacd | |
relation.isAuthorOfPublication.latestForDiscovery | e691a304-c784-411a-9349-f69fc9e9682a |
Files
Original bundle
1 - 1 of 1